A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
Hiroko Sugawara,1,2 Kaoru Sakamoto,1 Tsuyoto Harada,3 Satoru Shimizu,4 Jun Ishigooka1 1Department of Psychiatry, Tokyo Women’s Medical University, 2Support Center for Women Health Care Professionals and Researchers, Tokyo Women’s Medical University, Shinjuku-ku, 3Department of P...
Enregistré dans:
Auteurs principaux: | Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2a93f7b213cd419fa1ac95decd76ba59 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
par: Luan SX, et autres
Publié: (2018) -
Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
par: Subramanian Madhusoodanan, et autres
Publié: (2008) -
Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series
par: Sugawara Kikuchi Y, et autres
Publié: (2019) -
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
par: Berman R, et autres
Publié: (2011) -
Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder
par: Tsutsumi T, et autres
Publié: (2016)